BLU-285

/Tag: BLU-285

It’s a Journey: Our Experience on Clinical Trials

By Jennifer Moore, LRG Member I was waiting in line to pick up a new prescription for Gleevec when my husband ran in and told me to forget it. After two surgeries, a year [...]

By |2018-10-29T13:46:42+00:00December 28th, 2017|Clinical Trials, Member Stories, News, Newsletter|

GIST Patient Community Update on BLU-285 Clinical Program

Dr. Anthony Boral, Chief Medical Officer of Blueprint Medicines, provided an update on the clinical development of BLU-285, an investigational medicine being developed for patients with advanced GIST. The presentation included an [...]

By |2018-10-30T09:14:36+00:00July 6th, 2017|Clinical Trials, Webcast|

Update on Blueprint Medicines Clinical Trial for BLU-285

Recently a number of companies have begun to develop therapeutic options that target some of the rarer mutations in GIST. As there are currently no approved treatments specifically for these patients, this [...]

By |2018-10-30T09:50:21+00:00May 24th, 2016|Clinical Trials, News, Research|

Recent Posts

Upcoming Events

  1. GDOL Los Angeles 2019

    February 16, 2019 @ 8:00 AM - 5:00 PM